Therapeutic Potential of Caspofungin Combined with Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia: A Pilot Study in Mice

Pneumocystis pneumonia (PcP) is a major cause of mortality and morbidity in immunocompromised patients. There are limited alternative therapeutic choices to trimethoprim-sulfamethoxazole (TMP-SMX) which is the standard first line therapy/prophylaxis for PcP. The efficacy of low doses of caspofungin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobo, Maria Luísa, Esteves, Francisco, de Sousa, Bruno, Cardoso, Fernando, Cushion, Melanie T., Antunes, Francisco, Matos, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734247/
https://www.ncbi.nlm.nih.gov/pubmed/23940606
http://dx.doi.org/10.1371/journal.pone.0070619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734247/
https://www.ncbi.nlm.nih.gov/pubmed/23940606
http://dx.doi.org/10.1371/journal.pone.0070619

Ejemplares similares